Classical Homocystinuria clinical trials

Explore recruiting classical homocystinuria clinical trials.

Recruiting classical homocystinuria studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Classical Homocystinuria trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Parallel-group Treatment, Blinded, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of Pegtibatinase Administered Subcutaneously in Addition to Standard of Care in Participants with Classical Homocystinuria due to Cystathionine Beta Synthase Deficiency (HARMONY)

Belgium, Ireland, Spain, Italy, Germany, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 1/2 STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFECTS ON CLINICAL OUTCOMES OF PEGTIBATINASE (TVT-058) ADMINISTERED SUBCUTANEOUSLY IN SUBJECTS WITH CYSTATHIONINE BETASYNTHASE-DEFICIENT HOMOCYSTINURIA (COMPOSE)

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Classical Homocystinuria trials by city

Classical Homocystinuria in Toronto Classical Homocystinuria in Vancouver Classical Homocystinuria in Montreal Classical Homocystinuria in Calgary Classical Homocystinuria in Edmonton Classical Homocystinuria in Ottawa Classical Homocystinuria in Winnipeg Classical Homocystinuria in Quebec City Classical Homocystinuria in Hamilton Classical Homocystinuria in Kitchener Classical Homocystinuria in London Classical Homocystinuria in Halifax Classical Homocystinuria in New York Classical Homocystinuria in Los Angeles Classical Homocystinuria in Chicago Classical Homocystinuria in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease